Inventor

WISNIEWSKI THOMAS M

US8 patents

⚠️ This page may combine multiple inventors who share the name “WISNIEWSKI THOMAS M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV NEW YORK

5 patents

US9834582B2Dec 5, 2017

Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

UNIV NEW YORK4 citations81

US8951519B2Feb 10, 2015

Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

UNIV NEW YORK2 citations60

US11332506B2May 17, 2022

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides

UNIV NEW YORK0 citations59

US10253070B2Apr 9, 2019

Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

UNIV NEW YORK0 citations49

US10870709B2Dec 22, 2020

Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptides

UNIV NEW YORK0 citations39

WISNIEWSKI THOMAS M

3 patents

US8409584B2Apr 2, 2013

Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins

WISNIEWSKI THOMAS M9 citations80

US9574001B2Feb 21, 2017

Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis

WISNIEWSKI THOMAS M12 citations77

US9926353B2Mar 27, 2018

Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides

WISNIEWSKI THOMAS M1 citations48